What the fuck is this crap? This is BBgate/ the new hive.. AIBN, methyl thioglycolate, dimyristyl peroxydicarbonate thioglycolic acid? Can anyone get these easily or cheap? Is it safe for the avg chemist?
Shit just googling
DIMYRISTYL PEROXYDICARBONATE decomposes violently or explosively at temperatures 0-10°C owing to self-accelerating exothermic decomposition; Several explosions doesn't sound very ummmm unsafe for the avg chemist that would read this board. Hell it kinda reminds of this this guys username. And while meth chemists have been using AIBN to racemate meth on a bulk scale with D tartaric acid.
Clandestine chemists have also used NAPROXEN ages ago to convert the L into the racemate with heat. ... yes yes the NASID. This actually has a 2 fold advantage besides being safe, so really 3, 4 if count count it is accessible as all hell . The route is called a pope-peachy and i'll document everything for ya it really is as simple as it sounds
The trick is to find the cheapest optically active acid that will bind to one isomer but not the other and which will change solubility sufficiently so that one of the products (be it the unreacted freebase or the reacted amide, sulfonate or whatever) can be washed into another solvent (one that is immiscible with the first solvent) so you end up with one isomer dissolved in the first solvent, the other isomer dissolved in the second solvent.
Then the cool twist the meth makers use - the use of AIBN (which you all head by now) which will react with the secondary amine (via in imine) so that 50% of the less active/inactive isomer is transformed into the active isomer).
Below are examples of the class of racemization specified in the above paper. AIBN (azabisisobutyrlonitrile) is a catalyst for the radical reaction
https://www.academia.edu/81633940/T...Racemization_of_Nonactivated_Aliphatic_Amines
However this naproxen research it was based on... nothing new just old stuff but put 2 and 2 and bingo was his nameo the ideal Pope-Peachy. This resolution may have practical application because the efficiency of the resolution is in the same range as with tartaric acid but only 0.25 molar equivalent of resolving agent is required for the resolution of 1 mol base. Chirality 11:373–375, 1999. © 1999 Wiley-Liss, Inc.
Anyways PROFF it works on meth ohh IDK maybe this
Study of the mechanism of the optical resolution of N-methylamphetamine via diastereoisomeric salt formation by the Pope-Peachey resolution method as discussed by the retort later
https://sci-hub.wf/10.1016/s0957-4166(00)86170-4
https://www.sciencedirect.com/science/article/abs/pii/S0957416600861704
However ... instead of AIBN we use naproxen to turn l into racemic with heat . .Probably based on this retort I also found.. The same Pope-Peachy mentioned earlier .
As I said earlier...if the trick is to find the cheapest optically active acid that will bind to one isomer but not the other and which will change solubility sufficiently so that one of the products (be it the unreacted freebase or the reacted amide, sulfonate or whatever) can be washed into another solvent (one that is immiscible with the first solvent) so you end up with one isomer dissolved in the first solvent, the other isomer dissolved in the second solvent.
http://www1.udel.edu/chem/sametz/Sa..._Diastereomeric_Salt_Formation__Naproxen.html
The scheme
https://dump.li/image/ac34d7b4b88983a0.jpeg
The Retort
Resolution of Enantiomers via Diastereomeric Salt Formation: Naproxen
In my biochem slides from CHE322 the analgesic naproxen is resolved in a manner very similar to that discussed in CHE321. Naproxen is a chiral carboxylic acid, and it is the (d)-(S)- enantiomer that is sold as the active drug.
Racemic naproxen is resolved by a modification of the salt-formation technique we learned in class. There are two twists to the protocol that make the process even more useful for commercial production of enantiomerically pure naproxen. First, in a twist known as the Pope-Peachy method, only half an equivalent of chiral amine is used. Half an equivalent of a cheaper, optically inactive amine base is used in its place. This not only makes the process cheaper, but results in a more dramatic difference in solubilities. The conjugate base of the desired (d)-(+)-enantiomer crystallizes out with the conjugate acid of the chiral amine, with high selectivity. This leaves the more soluble salt product of (l)-(-)-naproxen and the achiral amine behind in solution.
The second twist is that, by simply heating the “mother liquor” (the solution that remains after filtration) , the undesired enantiomer of naproxen can be converted back to a racemate. You will learn in CHE322 that protons next to a carbonyl are modestly acidic; this means that if you have a methine stereocenter next to a carbonyl you always have to be wary that its configuration can get “scrambled” by deprotonation/reprotonation. In this case, however, we want the configuration to equilibrate back to a racemic mixture, and the achiral base that was used, plus heat, is enough to do the job.
This process allows naproxen to be synthesized by a simpler, cheaper route as a racemate instead of a single enantiomer. Not only can the two enantiomers be resolved by this process, but the “undesired” enantiomer is converted to the desired, rather than being discarded--effectively doubling the yield of product.
Reference: Harrington, P.J.; Lodewijk, E. “Twenty Years of Naproxen Technology”. Organic Process Research and Development, 1997, 1, 72-76.
Or this Non-enzymatic dynamic kinetic resolution of racemic α-arylalkanoic acids: an advanced asymmetric synthesis of chiral nonsteroidal anti-inflammatory drugs (NSAIDs)
An efficient protocol was developed to produce chiral 2-arylalkanoic esters in high yields (up to 99%) from racemic carboxylic acids utilizing the racemization of the mixed-anhydrides generated from acid components with pivalic anhydride in the presence of an acyl-transfer catalyst. The present DKR involves the enantio-discriminating esterification of the racemic 2-arylalkanoic acids and the rapid racemization of the chiral 2-arylalkanoic acids under suitable reaction conditions using pivalic anhydride, diisopropylethylamine, and benzotetramisole (BTM) in a polar solvent, and this method was successfully applied for the preparation of pharmacodynamically active (S)-enantiomers of nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen.
https://pubs.rsc.org/en/content/articlelanding/2012/cy/c2cy20329d
https://doi.org/10.1039/C2CY20329D
Someone told me they use naproxen but couldn't find anything... so I did some digging.